AfterQuery | $30,000,000 | (Apr 10, 2026)
Plume (YC S24) | $3,900,000 | (Apr 10, 2026)
Rork | $15,000,000 | (Apr 10, 2026)
Evrima Technologies
Australia
- Sydney, NSW
- 05/09/2022
- Unknown
- $3,000,000
Our vision is to be an innovative organisation that truly engages and enriches society through clinical trial awareness and participation. We are striving to make a global impact on overall clinical trial timelines and enable the industry to advance medical research swiftly.
Our mission is to automate the study start-up and patient recruitment processes using predictive technology to reduce inaccuracies, repetitive administrative headaches that study teams, sponsors and patients experience. Ultimately we want to have a direct impact on the overall time it takes for new and improved medicines to become available to those who need them.
- Industry Hospital & Health Care
- Website https://evrima.com.au/
- LinkedIn https://www.linkedin.com/company/evrimatechnologies/
Related People
Charlotte BradshawFounder
Australia -
ND
Experienced patient recruitment specialist with strong project management and digital marketing expertise across various therapeutic areas and trial phases. Client-focused and driven to achieve innovative solutions.
Haast | $12,000,000 | (Apr 10, 2026)
CareGlance Srl | $4,092,182 | (Apr 10, 2026)
Elorian AI | $55,000,000 | (Apr 10, 2026)
TeiaCare & Ancelia: AI for Care Homes | $8,184,645 | (Apr 10, 2026)
Sigma Automate | $2,750,000 | (Apr 10, 2026)
Felix(1) | $1,700,000 | (Apr 10, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
Golden Analytics | $7,000,000 | (Apr 9, 2026)